Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Natural Alternatives International, Inc. - SIC # 8092 - KIDNEY DIALYSIS CENTERS
Ticker
Exchange
SIC #
Website
Latest Ticker
NAII
Nasdaq
8092
www.nai-online.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Natural Alternatives International, Inc.
Natural Alternatives International and CarnoSyn® Brands Publish Clinical Research Demonstrating TriBsyn™ Delivering Exceptional Bioavailability, Increased Efficiency and Paresthesia Elimination
- Mar 5th, 2025 8:20 pm
Natural Alternatives International First Quarter 2025 Earnings: US$0.34 loss per share (vs US$0.12 loss in 1Q 2024)
- Nov 16th, 2024 12:17 pm
Natural Alternatives International, Inc. Announces 2025 Q1 Results
- Nov 13th, 2024 9:30 pm
CarnoSyn® Brands Announces New U.S. Distribution Agreement With B&D Nutritional Ingredients
- Oct 24th, 2024 9:50 pm
Natural Alternatives International, Inc. Announces Fiscal 2024 Q4 and YTD Results
- Sep 27th, 2024 11:20 pm
CarnoSyn® Brands Showcasing TriBsyn™ at the 46th ESPEN Congress On Clinical Nutrition & Metabolism
- Aug 26th, 2024 12:00 pm
CarnoSyn® Brands Unveils TriBsyn™ - “The World’s First Paresthesia-Free Beta-Alanine Powder”
- Aug 7th, 2024 12:00 pm
Natural Alternatives International, Inc. Announces Fiscal 2024 Q3 and YTD Results
- May 14th, 2024 8:30 pm
Scroll